← Back
Data updated: Mar 10, 2026
UROGEN PHARMA
Oncology
UROGEN PHARMA is a pharmaceutical company focused on Oncology. Key products include JELMYTO.
2020
Since
2
Drugs
-
Trials
2
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
2 drugs Phase 3: 7 Phase 2: 1 Phase 1: 1
Pipeline Strength Pro
Loading...